Clinical Trial Update: Evaluation of Abdominal Wall Block With Liposomal Bupivacaine for Post-Operative Analgesia in Donor Nephrectomy [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating abdominal wall block with liposomal bupivacaine for postoperative analgesia in donor nephrectomy; completed with results posted in 2021…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Donor Nephrectomy-related Postoperative Pain Management

Drugs mentioned

• Liposomal bupivacaine (bupivacaine liposome injectable suspension)

Snippet

Sponsor: University of California, Los Angeles | Conditions: Pain, Postoperative, Analgesics, Opioid | Phase 4 | Status: COMPLETED | Results posted: 2021-11-05